A Simple Solid-Phase Radioimmunoassay for Glutamic Acid Decarboxylase(GAD) Antibodies in Patients with Diabetes Mellitus.

DOI

抄録

Antibodies to glutamic acid decarboxylase (GAD Ab's) provide an important serologic marker for insulin-dependent diabetes mellitus (IDDM), but the diagnostic sensitivity and specificity of GAD antibodies have yet to be defined in assay systems suitable for screening a large number of samples. Therefore, using affinity purified GAD from rat brain we have developed a simple and sensitive solid-phase radioimmunoassay for measuring antibodies against the isoforms GAD65 and GAD67 and have examined a large number of serum samples from Japanese patients with IDDM of short-duration (less than 3 years) as well as from those with non-insulin-dependent diabetes mellitus (NIDDM). We detected GAD Ab in 62% (37 of 60) of the patients with IDDM, but only in 8% (4 of 51) of those with NIDDM. Almost all the patients with other autoimmune diseases and the healthy controls had no GAD Ab at all. Seventy-eight percent of the IDDM patients with GAD Ab concomitantly had islet cell cytoplasmic antibody (ICA), and there was a significant correlation between both autoantibody levels. This assay provides for rapid and simple screening for the early diagnosis of IDDM.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282679648805504
  • NII論文ID
    130003670388
  • DOI
    10.3164/jcbn.20.139
  • ISSN
    18805086
    09120009
  • 本文言語コード
    en
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ